BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33764590)

  • 1. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis.
    Soret PA; Lam L; Carrat F; Smets L; Berg T; Carbone M; Invernizzi P; Leroy V; Trivedi P; Cazzagon N; Weiler-Normann C; Alric L; Rosa-Hezode I; Heurgué A; Cervoni JP; Dumortier J; Potier P; Roux O; Silvain C; Bureau C; Anty R; Larrey D; Levy C; Pares A; Schramm C; Nevens F; Chazouillères O; Corpechot C
    Aliment Pharmacol Ther; 2021 May; 53(10):1138-1146. PubMed ID: 33764590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
    Gómez E; Montero JL; Molina E; García-Buey L; Casado M; Fuentes J; Simón MA; Díaz-González A; Jorquera F; Morillas RM; Presa J; Berenguer M; Conde MI; Olveira A; Macedo G; Garrido I; Hernández-Guerra M; Olivas I; Rodríguez-Tajes S; Londoño M; Sousa JM; Ampuero J; Romero-González E; González-Padilla S; Escudero-García D; Carvalho A; Santos A; Gutiérrez ML; Pérez-Fernández E; Aburruza L; Uriz J; Gomes D; Santos L; Martínez-González J; Albillos A; Fernández-Rodríguez CM
    Aliment Pharmacol Ther; 2024 Jun; 59(12):1604-1615. PubMed ID: 38690746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Reig A; Álvarez-Navascués C; Vergara M; Gómez-Domínguez E; Gallego-Moya A; Pérez-Medrano IM; Fábrega E; Hernández-Guerra M; Berenguer M; Estevez P; Arencibia A; Morillas RM; Horta D; Albillos A; Casado M; De la Cruz G; Fernandez-Bonilla E; Molina E; Hijona L; Diago M; Fernández-Rodriguez CM; González-Santiago JM; Sala M; Gómez-Camarero J; Romero-Gomez M; Suárez F; Vargas V; Ferre-Aracil C; Andrade RJ; Chahri N; Parés A
    Am J Gastroenterol; 2021 Nov; 116(11):2250-2257. PubMed ID: 34158466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional fibrate treatment in UDCA-refractory PBC patients.
    Chung SW; Lee JH; Kim MA; Leem G; Kim SW; Chang Y; Lee HY; Yoon JS; Park JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Yoon JH
    Liver Int; 2019 Sep; 39(9):1776-1785. PubMed ID: 31162879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis.
    Zhang H; Li S; Feng Y; Zhang Q; Xie B
    Clin Exp Med; 2023 Sep; 23(5):1741-1749. PubMed ID: 36318376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.
    Hirschfield GM; Mason A; Luketic V; Lindor K; Gordon SC; Mayo M; Kowdley KV; Vincent C; Bodhenheimer HC; Parés A; Trauner M; Marschall HU; Adorini L; Sciacca C; Beecher-Jones T; Castelloe E; Böhm O; Shapiro D
    Gastroenterology; 2015 Apr; 148(4):751-61.e8. PubMed ID: 25500425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
    Gomez E; Garcia Buey L; Molina E; Casado M; Conde I; Berenguer M; Jorquera F; Simón MA; Olveira A; Hernández-Guerra M; Mesquita M; Presa J; Costa-Moreira P; Macedo G; Arenas JI; Manuel Sousa J; Ampuero J; Morillas RM; Santos A; De Carvalho A; Uriz J; Carrión JA; Luisa Gutiérrez M; Pérez-Fernández E; Fernández-Rodríguez CM;
    Aliment Pharmacol Ther; 2021 Feb; 53(4):519-530. PubMed ID: 33314220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
    Levy C
    Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
    D'Amato D; De Vincentis A; Malinverno F; Viganò M; Alvaro D; Pompili M; Picciotto A; Palitti VP; Russello M; Storato S; Pigozzi MG; Calvaruso V; De Gasperi E; Lleo A; Castellaneta A; Pellicelli A; Cazzagon N; Floreani A; Muratori L; Fagiuoli S; Niro GA; Feletti V; Cozzolongo R; Terreni N; Marzioni M; Pellicano R; Pozzoni P; Baiocchi L; Chessa L; Rosina F; Bertino G; Vinci M; Morgando A; Vanni E; Scifo G; Sacco R; D'Antò M; Bellia V; Boldizzoni R; Casella S; Omazzi B; Poggi G; Cristoferi L; Gerussi A; Ronca V; Venere R; Ponziani F; Cannavò M; Mussetto A; Fontana R; Losito F; Frazzetto E; Distefano M; Colapietro F; Labanca S; Marconi G; Grassi G; Galati G; O'Donnell SE; Mancuso C; Mulinacci G; Palermo A; Claar E; Izzi A; Picardi A; Invernizzi P; Carbone M; Vespasiani-Gentilucci U;
    JHEP Rep; 2021 Apr; 3(2):100248. PubMed ID: 33681748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
    Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
    Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
    Abbas N; Culver EL; Thorburn D; Halliday N; Crothers H; Dyson JK; Phaw A; Aspinall R; Khakoo SI; Kallis Y; Smith B; Patanwala I; McCune A; Chimakurthi CR; Hegade V; Orrell M; Jones R; Mells G; Thain C; Thain RM; Jones D; Hirschfield G; Trivedi PJ
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1561-1570.e13. PubMed ID: 35961518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes.
    Cheung AC; Lapointe-Shaw L; Kowgier M; Meza-Cardona J; Hirschfield GM; Janssen HL; Feld JJ
    Aliment Pharmacol Ther; 2016 Jan; 43(2):283-93. PubMed ID: 26559762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
    Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review.
    Li X; Liao M; Pan Q; Xie Q; Yang H; Peng Y; Li Q; Qu J; Chai J
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1116-1122. PubMed ID: 32649329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Hegade VS; Khanna A; Walker LJ; Wong LL; Dyson JK; Jones DEJ
    Dig Dis Sci; 2016 Oct; 61(10):3037-3044. PubMed ID: 27435324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
    Ampuero J; Lucena A; Berenguer M; Hernández-Guerra M; Molina E; Gómez-Camarero J; Valdivia C; Gómez E; Casado M; Álvarez-Navascuez C; Jorquera F; García-Buey L; Díaz-González Á; Morillas R; García-Retortillo M; Sousa JM; Pérez-Medrano I; Simón MÁ; Martínez J; Arenas J; Londoño MC; Olveira A; Fernández-Rodríguez C;
    Hepatology; 2024 Mar; ():. PubMed ID: 38447019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cholangitis: treatment.
    Cazzagon N; Floreani A
    Curr Opin Gastroenterol; 2021 Mar; 37(2):99-104. PubMed ID: 33492001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
    Wong LL; Hegade VS; Jones DEJ
    Dig Dis; 2017; 35(4):359-366. PubMed ID: 28468009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of primary biliary cholangitis prior to obeticholic acid availability.
    Durazzo M; Bonetto S; Fagoonee S; Morgando A; Pellicano R
    Minerva Med; 2018 Dec; 109(6):410-417. PubMed ID: 30022645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.